David A. Karlin

1.4k total citations
48 papers, 1.1k citations indexed

About

David A. Karlin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, David A. Karlin has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in David A. Karlin's work include Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (10 papers) and Cancer Treatment and Pharmacology (8 papers). David A. Karlin is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (10 papers) and Cancer Treatment and Pharmacology (8 papers). David A. Karlin collaborates with scholars based in United States, Russia and Switzerland. David A. Karlin's co-authors include John R. Stroehlein, Marvin M. Romsdahl, Anthony J. Mastromarino, Jane E. Huang, Fang Ting Liang, Leonardo Faoro, Douglas McGregor, Frank A. Scappaticci, P. Townley and Mark A. Socinski and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

David A. Karlin

46 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Karlin United States 15 636 349 274 265 236 48 1.1k
Kyuya Ishibiki Japan 20 516 0.8× 403 1.2× 126 0.5× 248 0.9× 163 0.7× 105 1.3k
K Orita Japan 17 354 0.6× 319 0.9× 128 0.5× 183 0.7× 344 1.5× 122 1.2k
Kazuya Kitamura Japan 22 287 0.5× 552 1.6× 144 0.5× 252 1.0× 239 1.0× 69 1.4k
Hideo Baba Japan 18 422 0.7× 353 1.0× 205 0.7× 272 1.0× 520 2.2× 61 1.2k
Antonio Zanghì Italy 18 482 0.8× 435 1.2× 121 0.4× 274 1.0× 457 1.9× 88 1.4k
Jeong Kim South Korea 17 335 0.5× 301 0.9× 134 0.5× 208 0.8× 418 1.8× 56 1.2k
Haijun Zhong China 13 353 0.6× 318 0.9× 191 0.7× 279 1.1× 334 1.4× 59 1.1k
Ingrid Synnerstad Sweden 18 351 0.6× 232 0.7× 268 1.0× 175 0.7× 121 0.5× 24 855
Edward L. Lee United States 21 231 0.4× 274 0.8× 280 1.0× 330 1.2× 502 2.1× 49 1.3k
Takaaki Mizushima Japan 15 288 0.5× 328 0.9× 135 0.5× 114 0.4× 298 1.3× 34 886

Countries citing papers authored by David A. Karlin

Since Specialization
Citations

This map shows the geographic impact of David A. Karlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Karlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Karlin more than expected).

Fields of papers citing papers by David A. Karlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Karlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Karlin. The network helps show where David A. Karlin may publish in the future.

Co-authorship network of co-authors of David A. Karlin

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Karlin. A scholar is included among the top collaborators of David A. Karlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Karlin. David A. Karlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rugo, Hope S., Nikunj Sharma, Brian L. West, et al.. (2014). Phase Ib Study of Plx3397, a Csf1R Inhibitor, and Paclitaxel in Patients with Advanced Solid Tumors. Annals of Oncology. 25. iv148–iv148. 4 indexed citations
2.
Sharma, Neelesh, Robert Wesolowski, Brian L. West, et al.. (2014). A phase 1b study to assess the safety of PLX3397, a CSF-1 receptor inhibitor, and paclitaxel in patients with advanced solid tumors.. Journal of Clinical Oncology. 32(15_suppl). TPS3127–TPS3127. 11 indexed citations
3.
Hainsworth, John D., Fang Ting Liang, Jane E. Huang, et al.. (2010). BRIDGE: An Open-Label Phase II Trial Evaluating the Safety of Bevacizumab + Carboplatin/Paclitaxel as First-Line Treatment for Patients with Advanced, Previously Untreated, Squamous Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 6(1). 109–114. 48 indexed citations
4.
5.
Azarnoff, Daniel L., et al.. (2007). Quality of Extemporaneously Compounded Nitroglycerin Ointment. Diseases of the Colon & Rectum. 50(4). 509–516. 10 indexed citations
6.
Lanza, Frank L., et al.. (1990). Effect of enprostil on the gastroduodenal mucosa of healthy volunteers. Alimentary Pharmacology & Therapeutics. 4(6). 601–613. 5 indexed citations
7.
Karlin, David A., Robert S. Fisher, & Benjamin Krevsky. (1987). Prolonged survival and effective palliation in patients with squamous cell carcinoma of the esophagus following endoscopic laser therapy. Cancer. 59(11). 1969–1972. 29 indexed citations
8.
Kantarjian, Hagop M., Jaffer A. Ajani, & David A. Karlin. (1985). Cis-Diaminodichloroplatinum (II) Chemotherapy for Advanced Adenocarcinoma of the Upper Gastrointestinal Tract. Oncology. 42(2). 69–71. 18 indexed citations
9.
DiPalma, Jack A., et al.. (1984). Comparison of Colon Cleansing Methods in Preparation for Colonoscopy. Gastroenterology. 86(5). 856–860. 85 indexed citations
10.
McGregor, Douglas, et al.. (1983). Comparison of effects of pentagastrin and gastrin on rat colon mucosa. Journal of Surgical Research. 34(4). 325–331. 9 indexed citations
11.
McGregor, Douglas, et al.. (1982). Trophic Effects of Gastrin on Colorectal Neoplasms in the Rat. Annals of Surgery. 195(2). 219–223. 79 indexed citations
12.
Karlin, David A., Richard D. Jones, John R. Stroehlein, Anthony J. Mastromarino, & G.D. Potter. (1982). Breath Methane Excretion in Patients With Unresected Colorectal Cancer<xref ref-type="fn" rid="fn2">2</xref>. JNCI Journal of the National Cancer Institute. 69(3). 573–6. 36 indexed citations
13.
Karlin, David A., et al.. (1981). CIS-platinum chemotherapy for advanced gastrointestinal cancer. Proceedings of the American Association for Cancer Research. 22. 1 indexed citations
14.
Stroehlein, John R., Agop Y. Bedikian, & David A. Karlin. (1981). A randomized study of oral ftorafur VS. IV 5-fluorouracil in advanced colorectal cancer. Proceedings of the American Association for Cancer Research. 22. 2 indexed citations
15.
Karlin, David A., et al.. (1981). Combination 5-fluorouracil, adriamycin, mitomycin-C, and methyl CCNU (FAMMe) chemotherapy for advanced gastrointestinal cancer. Proceedings of the American Association for Cancer Research. 22.
16.
Bedikian, Agop Y., et al.. (1981). Chemotherapy for colorectal cancer with a combination of PALA and 5-FU.. PubMed. 65(9-10). 747–53. 21 indexed citations
17.
Smith, Frederick P., Daniel F. Hoth, Bernard Levin, et al.. (1980). 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas. Cancer. 46(9). 2014–2018. 93 indexed citations
18.
Karlin, David A., et al.. (1980). Effect of dioctyl sodium sulfosuccinate feeding on rat colorectal 1,2-dimethylhydrazine carcinogenesis.. PubMed. 64(4). 791–3. 5 indexed citations
19.
Bresalier, Robert S. & David A. Karlin. (1979). Meningeal metastasis from rectal carcinoma with elevated cerebrospinal fluid carcinoembryonic antigen. Diseases of the Colon & Rectum. 22(4). 216–217. 9 indexed citations
20.
Karlin, David A., et al.. (1978). Tritiated thymidine (3H-TdR) labeling of pancreatic ductal cells in dogs. Gastroenterology. 74(5). 1009–1009. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyuya Ishibiki Breakdown of academic impact, for papers by K Orita Breakdown of academic impact, for papers by Kazuya Kitamura Breakdown of academic impact, for papers by Hideo Baba Breakdown of academic impact, for papers by Antonio Zanghì Breakdown of academic impact, for papers by Jeong Kim Breakdown of academic impact, for papers by Haijun Zhong Breakdown of academic impact, for papers by Ingrid Synnerstad Breakdown of academic impact, for papers by Edward L. Lee Breakdown of academic impact, for papers by Takaaki Mizushima
Rankless by CCL
2026